These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8446596)

  • 1. Cancer dormancy: isolation and characterization of dormant lymphoma cells.
    Yefenof E; Picker LJ; Scheuermann RH; Tucker TF; Vitetta ES; Uhr JW
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1829-33. PubMed ID: 8446596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice.
    Racila E; Scheuermann RH; Picker LJ; Yefenof E; Tucker T; Chang W; Marches R; Street NE; Vitetta ES; Uhr JW
    J Exp Med; 1995 Apr; 181(4):1539-50. PubMed ID: 7535341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer dormancy: lessons from a B cell lymphoma and adenocarcinoma of the prostate.
    Rabinovsky R; Uhr JW; Vitetta ES; Yefenof E
    Adv Cancer Res; 2007; 97():189-202. PubMed ID: 17419946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor dormancy and cell signaling. V. Regrowth of the BCL1 tumor after dormancy is established.
    Vitetta ES; Tucker TF; Racila E; Huang YW; Marches R; Lane N; Scheuermann RH; Street NE; Watanabe T; Uhr JW
    Blood; 1997 Jun; 89(12):4425-36. PubMed ID: 9192767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer dormancy: studies of the murine BCL1 lymphoma.
    Uhr JW; Tucker T; May RD; Siu H; Vitetta ES
    Cancer Res; 1991 Sep; 51(18 Suppl):5045s-5053s. PubMed ID: 1884380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer dormancy. VII. A regulatory role for CD8+ T cells and IFN-gamma in establishing and maintaining the tumor-dormant state.
    Farrar JD; Katz KH; Windsor J; Thrush G; Scheuermann RH; Uhr JW; Street NE
    J Immunol; 1999 Mar; 162(5):2842-9. PubMed ID: 10072532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Regulatory B Cell-Like Malignant Cells and Treg Cells in the Mouse Model of BCL1 Tumor Dormancy.
    BitMansour A; Pop LM; Vitetta ES
    PLoS One; 2016; 11(12):e0167618. PubMed ID: 27959896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of B cell tumor dormancy by anti-idiotypic antibodies.
    Yefenof E; Picker LJ; Scheuermann RH; Vitetta ES; Street NE; Tucker TF; Uhr JW
    Curr Opin Immunol; 1993 Oct; 5(5):740-4. PubMed ID: 8240736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-cell vaccination induces tumor dormancy in a murine model of B-cell leukemia/lymphoma (BCL1).
    Morecki S; Pugatsch T; Levi S; Moshel Y; Slavin S
    Int J Cancer; 1996 Jan; 65(2):204-8. PubMed ID: 8567118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor dormancy. I. Regression of BCL1 tumor and induction of a dormant tumor state in mice chimeric at the major histocompatibility complex.
    Siu H; Vitetta ES; May RD; Uhr JW
    J Immunol; 1986 Aug; 137(4):1376-82. PubMed ID: 3525678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new in vivo and in vitro B cell lymphoma model, pi-BCL1.
    Illidge T; Honeychurch J; Howatt W; Ross F; Wilkins B; Cragg M
    Cancer Biother Radiopharm; 2000 Dec; 15(6):571-80. PubMed ID: 11190489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dormancy in a model of murine B cell lymphoma.
    Uhr JW; Marches R
    Semin Cancer Biol; 2001 Aug; 11(4):277-83. PubMed ID: 11513563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical models of cancer dormancy.
    Page K; Uhr JW
    Leuk Lymphoma; 2005 Mar; 46(3):313-27. PubMed ID: 15621821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cytokines in termination of the B cell lymphoma dormant state in AKR mice.
    Peled A; Tzehoval E; Haran-Ghera N
    Leukemia; 1995 Jun; 9(6):1095-101. PubMed ID: 7596176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of B-cell lymphoma growth in syngeneic SJL/J mice. establishment of tumor dormancy following administration of anti-CD4 monoclonal antibody into tumor-bearing mice.
    Ohnishi K; Bonavida B
    Leukemia; 1993 Nov; 7(11):1801-6. PubMed ID: 8231249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growth.
    Bohlen H; Thielemanns K; Tesch H; Engert A; Wolf HJ; van Camp B; Urbain J; Diehl V
    Cytokines Mol Ther; 1996 Dec; 2(4):231-8. PubMed ID: 9384709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells.
    Scheuermann RH; Racila E; Tucker T; Yefenof E; Street NE; Vitetta ES; Picker LJ; Uhr JW
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):4048-52. PubMed ID: 7513431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour dormancy and cell signalling--III: Role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells.
    Marches R; Racila E; Tucker TF; Picker L; Mongini P; Hsueh R; Vitetta ES; Scheuermann RH; Uhr JW
    Ther Immunol; 1995 Jun; 2(3):125-36. PubMed ID: 8885131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics.
    George AJ; Spellerberg MB; Stevenson FK
    J Immunol; 1988 Mar; 140(5):1695-701. PubMed ID: 3162250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Termination of the B cell lymphoma dormant state in thymectomized AKR mice.
    Haran-Ghera N; Peled A; Brightman BK; Fan H
    J Immunol; 1992 May; 148(9):2947-52. PubMed ID: 1349324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.